Targeting long non-coding RNA to therapeutically upregulate gene expression

Area of Science:

• Molecular Biology
• Genetics
• Pharmacology

Background:

• Current drugs primarily inhibit biological processes, creating a need for agents that can enhance pathway activity.
• Upregulating specific genes, such as tumor suppressors or those deficient in genetic disorders, holds therapeutic promise.
• Regulatory long non-coding RNAs (lncRNAs) are emerging as critical regulators of gene expression and chromatin structure.

Purpose of the Study:

• To review the mechanisms by which lncRNAs regulate gene expression.
• To explore the role of lncRNAs in various diseases.
• To discuss the development and therapeutic potential of antagoNAT oligonucleotides targeting natural antisense transcripts (NATs).

Main Methods:

• Literature review of lncRNA mechanisms and roles in disease.
• Focus on antagoNAT oligonucleotides as inhibitors of NAT lncRNAs.
• Analysis of challenges in therapeutic applications of antagoNATs.

Main Results:

• lncRNAs can both activate and repress gene expression and influence chromatin architecture.
• NATs represent a class of lncRNAs amenable to inhibition by oligonucleotide-based therapeutics.
• The design and application of antagoNAT oligonucleotides are advancing.

Conclusions:

• lncRNAs are versatile regulators with significant implications for disease.
• AntagoNAT oligonucleotides offer a novel strategy for therapeutic intervention by targeting lncRNAs.
• Further research is needed to address challenges for the clinical translation of antagoNAT-based therapies.